Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kansas Regenerative Medicine Center is a medical facility specializing in autologous stem cell therapies and regenerative medicine treatments. The center primarily utilizes Stromal Vascular Fraction (SVF), which contains adult stem cells derived from the patient's own adipose tissue, to treat various orthopedic, neurological, and autoimmune conditions. Their clinical model focuses on point-of-care delivery, where tissue is harvested, processed, and deployed within a single outpatient procedure. Based in Manhattan, Kansas, the clinic serves patients seeking alternatives to invasive surgery for joint pain and chronic degenerative diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kansas Regenerative Medicine Clinic.